Location History:
- Ibaraki, JP (2017)
- Tsukuba, JP (2020)
Company Filing History:
3 out of 1,715 
2 out of 11 
1 out of 25 Years Active: 2017-2020
Title: Takashi Ohkura: Innovator in Glycan Markers for Cancer Diagnosis
Introduction
Takashi Ohkura is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to the field of medical diagnostics. He holds three patents that focus on the development of glycan markers for the diagnosis of lung cancer and hepatic diseases. His work aims to enhance the sensitivity and convenience of cancer diagnosis, providing valuable tools for healthcare professionals.
Latest Patents
One of Ohkura's latest patents is centered on a lung cancer differential marker. The objective of this invention is to develop a marker that allows for the convenient and highly sensitive diagnosis of lung cancer, independent of the fluctuations in protein expression levels between cancer patients and healthy individuals. Additionally, this patent includes the development of a glycan marker capable of distinguishing between different histological types of lung cancer. The research identified specific glycopeptides and glycoproteins whose glycan structures are altered in lung cancer cell culture supernatants, providing a novel approach to lung cancer diagnosis.
Another significant patent focuses on glycan markers as measures of disease states in hepatic diseases. This invention aims to create a glycan marker that can detect hepatic diseases, particularly hepatocarcinoma. The research identifies glycan structures that change specifically due to hepatic diseases, offering new glycan markers that can indicate the progression of these conditions.
Career Highlights
Throughout his career, Takashi Ohkura has worked with esteemed institutions such as the National Institute of Advanced Industrial Science and Technology and Tokyo Medical University. His research has significantly advanced the understanding of glycan markers in the context of cancer diagnosis.
Collaborations
Ohkura has collaborated with notable colleagues, including Hisashi Narimatsu and Akira Togayachi, contributing to the advancement of research in glycan markers and their applications in medical diagnostics.
Conclusion
Takashi Ohkura's innovative work in developing glycan markers for lung cancer and hepatic diseases represents a significant advancement in medical diagnostics. His contributions have the potential to improve the accuracy and efficiency of cancer diagnosis, ultimately benefiting patient care.